The global vutrisiran industry is experiencing unprecedented growth, with market valuation rising from USD 671.96 Million in 2023 to an anticipated USD 2,087 Million by 2033, registering a robust CAGR of 12% during the forecast period from 2023 to 2033. This impressive expansion underscores the pivotal role of vutrisiran in addressing unmet medical needs for hereditary …
Category Archives: Healthcare Trends
Global Skull Clamp Industry Set to Surge with Projected Valuation of USD 5.07 Billion by 2033, at a 9% CAGR
The global skull clamp industry is poised for significant growth, with an estimated valuation of USD 2.14 billion in 2023 expected to climb to USD 5.07 billion by 2033. This impressive expansion, driven by a compound annual growth rate (CAGR) of 9%, reflects the increasing demand for advanced neurosurgical tools and the prevalence of neurological disorders …
Upsurge in Edentulous People Creates Lucrative Opportunities for Growth Strategy Acrylic Teeth Industry to Register a CAGR of 8.5% through 2033
The revenue from the acrylic teeth industry is predicted to grow from USD 440.39 million in 2023 to USD 995.72 million by 2033. Between 2023 and 2033, a CAGR of 8.5% is predicted. The rise in government initiatives, soaring demand for dental cosmetic procedures, and an increasing edentulous population are all listed as contributing factors in …
Global Respiratory Distress Syndrome Management Industry Poised for Significant Growth to Reach USD 177.7 Billion by 2033
A recent study conducted by Future Market Insights (FMI) has shed light on the anticipated growth trajectory of the global respiratory distress syndrome management market. The findings reveal a compelling outlook, with projections indicating a substantial expansion from USD 115.4 billion in 2023 to USD 177.7 billion by 2033. This growth represents a steady compound …
Global Cerebral Vein Thrombosis Treatment Industry Expected to Reach USD 611 Million by 2033
The global cerebral vein thrombosis treatment industry, valued at USD 191.53 million in 2023, is set to witness a substantial growth trajectory with a projected Compound Annual Growth Rate (CAGR) of 12.3% during the forecast period from 2023 to 2033. By the end of 2033, the market is anticipated to soar to an estimated value …
Global Autoimmune Disease Testing Industry Poised for Remarkable Growth, Set to reach USD 15.75 billion by 2033
According to Future Market Insights (FMI), the global autoimmune disease testing industry is on a trajectory of robust growth. Estimated at USD 6.07 billion in 2023, the market is projected to expand at a 10% compound annual growth rate (CAGR), reaching an impressive USD 15.75 billion by 2033. This growth is driven by an alarming …
Central Nervous System Lymphoma Treatment Industry to reach USD $ 205.3 Billion by 2033; Growing at a 5.2% CAGR: FMI Study
According to Future Market Insights, the central nervous system lymphoma treatment industry is projected to rise at a steady growth valued at USD 123.2 billion with a 5.2% CAGR until 2033, being valued at USD 205.3 billion. The rapid advancements in diagnostics and therapeutics of the central nervous system (CNS) disease significantly contribute to market …
Global Pet Cancer Therapeutics Industry Poised for Significant Growth: Projected to Reach USD 898.6 Million by 2034
The global pet cancer therapeutics industry is set to experience extraordinary growth, with projections indicating a rise in sales from USD 400.9 million in 2024 to USD 898.6 million by 2034. This expansion reflects a robust compound annual growth rate (CAGR) of 8.4% over the forecast period from 2024 to 2034. In 2023, the market …
High Tibial Osteotomy Plates Leading the Way in Orthopedic Innovations: FMI Predicts Market to Surpass USD 355.9 million by 2033
In 2023, the global high tibial osteotomy plates industry is expected to be worth USD 235.91 million. The market is anticipated to expand at a 4.2% CAGR to reach USD 355.98 million by 2033. The increasing prevalence of osteoarthritis and other musculoskeletal conditions among the aging population is driving the demand for high tibial osteotomy …
Global ESR1 Mutated Metastatic Breast Cancer Diagnostics Industry to Witness Robust Growth is projected to reach USD 89.6 million by 2034 Amid Rising Awareness and Technological Advancements | FMI
The global ESR1 mutated metastatic breast cancer diagnostics industry is poised for significant expansion, with an anticipated year-over-year (y-o-y) growth rate of 4.0%. The market size is projected to grow from USD 63.4 million in 2024 to USD 89.6 million by 2034, reflecting a compound annual growth rate (CAGR) of 3.7% during the forecast period. …